All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: CON
Authors:
Open Access
- 22 November 2023
- journal article
- editorial
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (4) , 495-498
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 23 references indexed in Scilit:
- MR Brain Screening in ADPKD PatientsClinical Neuroradiology, 2021
- Procedural Clinical Complications, Case-Fatality Risks, and Risk Factors in Endovascular and Neurosurgical Treatment of Unruptured Intracranial AneurysmsJAMA Neurology, 2019
- Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effectiveKidney International, 2018
- Unruptured intracranial aneurysms: development, rupture and preventive managementNature Reviews Neurology, 2016
- Vascular complications in autosomal dominant polycystic kidney diseaseNature Reviews Nephrology, 2015
- Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2015
- Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studiesThe Lancet Neurology, 2014
- Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysisThe Lancet Neurology, 2011
- Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney diseaseJournal of Neurology, 2003
- Familial intracranial aneurysmsThe Lancet, 1997